Pranlukast
CAS number: 103177-37-3
Molecular formula: C27H23N5O4
molecular weight: 481.50
Chemical structure:
Producers shown on SFDA
(Record date:19/10/2021)
Producer | Documents | GMP Valid till(based on SFDA) |
Chongqing Shenghuaxi Pharmaceutical Co., Ltd. | GMP | Valid till September 2023 |
Jiangsu Hengrui Medicine Co.,Ltd. | GMP | Valid till June 2020 |
Producers shown on EP
Producer:Chongqing Shenghuaxi Pharmaceutical Co., Ltd. was established in 1998 and officially restructured into a joint stock limited company in 2010; At present, the company has more than 900 employees. After more than ten years of development, it has been established Jingjing is a high-tech API and pharmaceutical preparation enterprise integrating R & D, production and sales.
Taking new drug R & D as the core competitiveness of the enterprise, the company has built a large-scale scientific research system, with more than 200 full-time scientific and technological developers; The company invests more than 12% of its sales revenue into new drug research and development every year. The company has three production bases, with more than ten fully sterile API and non sterile API production workshops, fine, drying and charter workshops, as well as a number of pharmaceutical preparation workshops; It has an annual production capacity of more than one billion yuan for APIs and pharmaceutical preparations.
Staff size:About 800 persons
Registered capital:RMB 66 million
Producer:Jiangsu Hengrui Medicine Co.,Ltd. is a pharmaceutical company engaged in the development and commercialization of innovative and high-quality drugs. The company has 28000 employees globally, fifth R & D centers were built around the globe and several subsidiaries were established in the US, EU, and Japan. The company has 10 manufacturing facilities and most of them maintain USP, EUP, and JP. We are the first Chinese company that exported injections on a large scale to the US, EU, and Japan markets. All dosage forms of the company have passed the national GMP certification, and ifosfamide, etoposide, mesilar and tiotepa have passed the verification of FDA. Staff size:About 30000 persons Registered capital:RMB 6 billion 397 million
For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978